The epigenetic gene regulator BMI1 induces neural stem cell self-renewal in vitro and in vivo, a function that could be useful in regenerative medicine. However, increased expression of BMI1 in medulloblastoma, a brain tumour that can arise from cerebellar granule cell progenitors (CGPs), suggests that BMI1 is oncogenic in some circumstances. Behesti et al. investigated this possibility by generating transgenic mice that overexpress Bmi1 in the granule cell lineage. Bmi1 overexpression in CGPs decreased cerebellar size by decreasing CGP proliferation, whereas its overexpression in postmitotic granule cells improved cell survival under stress. No medulloblastomas developed in the transgenic mice, but Bmi1 overexpression in a Trp53−/− background produced a low incidence of medulloblastomas. Thus, BMI1 overexpression is not sufficient to induce neoplastic transformation but can improve neuronal survival under stress. These results have implications for regenerative therapies. Page 49
Bmi1, medulloblastoma and regenerative therapy
Bmi1, medulloblastoma and regenerative therapy. Dis Model Mech 1 January 2013; 6 (1): 1. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2023: Infectious Diseases Through an Evolutionary Lens

The abstract submission deadline for our 2023 Journal Meeting ‘Infectious Diseases Through an Evolutionary Lens’ is 14 July 2023. Find out more and register here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Propose a new Workshop for 2025

Do you have an idea for a Workshop? If so, click here. We are now accepting proposals for our 2025 Workshops programme. As the scientific organiser, your involvement will be focused on the science. We'll take care of all the logistics. In 2025 we'll continue our efforts to diversify our Workshop programme and will be reserving one of our Workshops for an application from a Global South country to host an event overseas.
How stromal cells restrict liver cancer invasion

In our recent editor’s choice, Liqin Zhu and colleagues describe how they used in vitro liver spheroid models consisting of both parenchymal and non-parenchymal cells to reveal a hepatoprotective role for peritumoral hepatic stellate cells in liver tumorigenesis.
And from perspective… Hacking haematopoiesis – emerging tools for examining variant effects

Thousands of genomic loci have been linked to hematopoietic traits and diseases, yet many await functional validation. Michael Gundry and Vijay G. Sankaran discuss recent advances in genome editing and the challenges associated with using these techniques to assess variant function in primary hematopoietic cells.
Other journals from
The Company of Biologists